1. Home
  2. PLSE vs OCFC Comparison

PLSE vs OCFC Comparison

Compare PLSE & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • OCFC
  • Stock Information
  • Founded
  • PLSE 2014
  • OCFC 1902
  • Country
  • PLSE United States
  • OCFC United States
  • Employees
  • PLSE N/A
  • OCFC N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • OCFC Major Banks
  • Sector
  • PLSE Health Care
  • OCFC Finance
  • Exchange
  • PLSE Nasdaq
  • OCFC Nasdaq
  • Market Cap
  • PLSE 1.0B
  • OCFC 1.2B
  • IPO Year
  • PLSE 2016
  • OCFC 1996
  • Fundamental
  • Price
  • PLSE $20.30
  • OCFC $21.15
  • Analyst Decision
  • PLSE
  • OCFC Hold
  • Analyst Count
  • PLSE 0
  • OCFC 4
  • Target Price
  • PLSE N/A
  • OCFC $20.00
  • AVG Volume (30 Days)
  • PLSE 217.5K
  • OCFC 252.0K
  • Earning Date
  • PLSE 10-30-2024
  • OCFC 01-16-2025
  • Dividend Yield
  • PLSE N/A
  • OCFC 3.76%
  • EPS Growth
  • PLSE N/A
  • OCFC N/A
  • EPS
  • PLSE N/A
  • OCFC 1.74
  • Revenue
  • PLSE N/A
  • OCFC $380,971,000.00
  • Revenue This Year
  • PLSE N/A
  • OCFC N/A
  • Revenue Next Year
  • PLSE N/A
  • OCFC $4.30
  • P/E Ratio
  • PLSE N/A
  • OCFC $12.21
  • Revenue Growth
  • PLSE N/A
  • OCFC N/A
  • 52 Week Low
  • PLSE $6.60
  • OCFC $13.41
  • 52 Week High
  • PLSE $22.69
  • OCFC $21.87
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 63.68
  • OCFC 64.33
  • Support Level
  • PLSE $15.62
  • OCFC $18.81
  • Resistance Level
  • PLSE $17.20
  • OCFC $21.87
  • Average True Range (ATR)
  • PLSE 1.41
  • OCFC 0.64
  • MACD
  • PLSE 0.21
  • OCFC 0.05
  • Stochastic Oscillator
  • PLSE 87.97
  • OCFC 76.47

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management services.

Share on Social Networks: